Mohammed Abdul-Matin

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study

Z. Memish, Kamran Baig, A. Albarrak, 2014, The Lancet Infectious Diseases.